$RGBP During the call 2 weeks ago, CEO Koos clearly said they had not even begun the application process. Now, last week's PR says the application was filed. Something smells! "Following the recent submission of an Orphan Drug Application for the treatment of aplastic anemia"

$RGBP Yet another Koos lie? In the last video conference he talked about the offering funds being used to pay off the ridiculous toxic debt he just took on in the last 2 months, but instead look what is said in the offering doc, "Use of Proceeds"! #scam otcmarkets.com/filing/html?id…

$RGBP CEO David Koos is the ultimate scam spin Dr! He PRed the FDA's rejection of their orphan drug application as "preparing a response" to the FDA! Nice one! nasdaq.com/press-release/…

I listened to the $RGBP video conference presentation today. Anyone want to bet me that Phase 1 testing won't start in 30 days, as CEO Koos said it would? We should have a pool for how many months past 30 days it will be without beginning Phase 1 testing. #obviouslie #scammer

$RGBP CEO Koos is likely responding to FDA deficiency letters. There is no limit to this. Koos can milk this for a year or more, and likely he will as long as his faithful keep buying this scam. There will be no Orphan drug approval. The only orphans are the shareholders $'s!

$RGBP One sad truth to this scam is that what Koos said is correct about buyers of the offering wanting to avoid a 5% position. The market cap is $500k, so 5% is only $25k! Amazing. How is this fool going to raise $100's of K's? (he's not, but he'll fatten his expense wallet!)

Don't talk, but instead SHOW your belief in the "absurdly low valuation" by purchasing shares yourself, and posting the position. But the fact is RGBP paid you for for doing these reports. Go ahead, deny that and I'll forward your post to the SEC! $RGBP #scam

Could $RGBP CEO Koos be any more evasive when asked if the company owned a patent on Hemaxellerate, which they plan to test? The dancing around the question was personally embarrassing. #nopatent #scam A simple "yes, it's patent number xxx" would do. youtu.be/suvDPUB4a-I?si…

$RGBP's paid reports are "golden". 1st we heard "Bargain basement prices" @ 2.6c Then we heard "Verge of Major Event" @ 1.4c Then @ 1c we heard "Trial Launch to Drive Major Valuation". And now at 0.9c we get "Poised to Enjoy Strong Start to '26" goldmansmallcapresearch.com

$RGBP How much more obvious can a scam be when the supposed drug they want to raise money to test has an expired patent? Who in their right mind would take a drug through testing when after all that effort and $, any other company could also manufacture and sell it? Regen BioPharma Inc.

You keep hitting on unignorable major points that should show any reasonable person $RGBP is a scam. Anyone spending 30 minutes researching the history of ClinDatrix Inc , who $RGBP chose to do testing, would know this is a #scam Scams hire scams.

Correct, but the faithful (but uninformed) shareholders get excited that there is communication with the FDA. It makes them feel that this is "real", which is all they want. The fact that the communication is rejection after rejection will NEVER be revealed by the CEO! $RGBP

$RGBP As typical of scam companies, even their regulatory filings often have obvious careless errors in them which true businesses would catch. Example, in the Dec 5 filing - "We will have approximately common shares issued and outstanding if we sell all shares allowable".

Anyone that owns stock in $RGBP and hasn't bothered to look up the history and results of CEO Koos' decades of running scams, with $millions in losses to shareholders, deserves every penny of their current losses, plus those to come!

$RGBP Shareholders, you've just been Koos'ed again! Koos filed today to cut the offering price again, this time from 0.01 to 0.0045!

Updating this. Since the "Poised for Strong Start to 26" call, $RGBP is DOWN 76% in 2026. Yes, -76% in just 40 days, and now at 0.0024 This is what naturally happens when $RGBP pays goldmansmallcapresearch.com to do paid "reports", recommending them.

2 min opening pleasantries, 5 min repeating what has been said on prior calls, plus a lot of "umm's", 2 min taking only softball questions including the mandatory, vague, misleading answer to "are you hearing from others that are interested in $RGBP's science?", 1 min signoff.